Clinical Trial Update: Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating add-on tofacitinib for efficacy and safety in Oral Lichen Planus; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Lichen Planus

Drugs mentioned

• Tofacitinib (Xeljanz) (tofacitinib)

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Oral Lichen Planus | Phase 4 | Status: RECRUITING